Artiva Biotherapeutics (ARTV) Current Leases (2023 - 2025)
Historic Current Leases for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $3.1 million.
- Artiva Biotherapeutics' Current Leases fell 1430.55% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 1430.55%. This contributed to the annual value of $3.6 million for FY2024, which is 61.18% up from last year.
- Latest data reveals that Artiva Biotherapeutics reported Current Leases of $3.1 million as of Q3 2025, which was down 1430.55% from $3.5 million recorded in Q2 2025.
- Artiva Biotherapeutics' Current Leases' 5-year high stood at $3.7 million during Q2 2024, with a 5-year trough of $3.1 million in Q3 2025.
- In the last 3 years, Artiva Biotherapeutics' Current Leases had a median value of $3.6 million in 2023 and averaged $3.5 million.
- As far as peak fluctuations go, Artiva Biotherapeutics' Current Leases skyrocketed by 61.18% in 2024, and later tumbled by 1430.55% in 2025.
- Quarter analysis of 3 years shows Artiva Biotherapeutics' Current Leases stood at $3.6 million in 2023, then increased by 0.61% to $3.6 million in 2024, then dropped by 14.4% to $3.1 million in 2025.
- Its last three reported values are $3.1 million in Q3 2025, $3.5 million for Q2 2025, and $3.6 million during Q1 2025.